The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from PR Newswire

Onyx Pharmaceuticals, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Amgen

Monday, August 26, 2013

Onyx Pharmaceuticals, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Amgen

12:47 EDT Monday, August 26, 2013

NEW YORK, Aug. 26, 2013 /PRNewswire/ -- Bernstein Liebhard LLP is investigating whether the Board of Directors of Onyx Pharmaceuticals, Inc. ("Onyx" or the "Company") (NASDAQ: ONXX) breached its fiduciary duty to its shareholders in agreeing to sell Onyx to Amgen.

(Logo: http://photos.prnewswire.com/prnh/20120202/MM47134LOGO )

Under the terms of the agreement, Onyx shareholders will receive $125.00 in cash for each share they own.  The investigation is focused on the potential unfairness of the price to Onyx shareholders and the process by which the Onyx Board of Directors considered and approved the transaction.

If you are interested in discussing your rights as an Onyx stockholder, with no obligation or cost to you, please contact Joseph Seidman at:

(877) 779-1414 or seidman@bernlieb.com.

Bernstein Liebhard LLP has pursued hundreds of securities, consumer and shareholder rights cases and recovered over $3 billion for its clients.  It has been named to The National Law Journal's "Plaintiffs' Hot List" in each of the last ten years.

Bernstein Liebhard LLP 10 East 40th Street New York, New York 10016 (877) 779-1414 www.bernlieb.com

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP.  The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.  The lawyer responsible for this advertisement in the State of Connecticut is Michael S. Bigin.  Prior results do not guarantee or predict a similar outcome with respect to any future matter.

SOURCE Bernstein Liebhard LLP

Products
  • Globe Unlimited

    Digital all access pass across devices. subscribe

  • The Globe and Mail Newspaper

    Newspaper delivered to your doorstep. subscribe

  • Globe2Go

    The digital replica of our newspaper. subscribe

  • Globe eBooks

    A collection of articles by the Globe. subscribe

See all Globe Products

Advertise with us

GlobeLink.ca

Your number one partner for reaching Canada's Influential Achievers. learn more

The Globe at your Workplace
Our Company
Customer Service
Globe Recognition
Mobile Apps
NEWS APP
INVESTING APP
Other Sections